172 related articles for article (PubMed ID: 32968597)
1. Estimation of Alpha-Synuclein Monomer and Oligomer Levels in the Saliva of the Children With Autism Spectrum Disorder: A Possibility for an Early Diagnosis.
Siddique A; Khan HF; Ali S; Abdullah A; Munir H; Ariff M
Cureus; 2020 Aug; 12(8):e9936. PubMed ID: 32968597
[TBL] [Abstract][Full Text] [Related]
2. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.
Cao Z; Wu Y; Liu G; Jiang Y; Wang X; Wang Z; Feng T
Neurosci Lett; 2019 Mar; 696():114-120. PubMed ID: 30579996
[TBL] [Abstract][Full Text] [Related]
3. Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson's Disease.
Vivacqua G; Latorre A; Suppa A; Nardi M; Pietracupa S; Mancinelli R; Fabbrini G; Colosimo C; Gaudio E; Berardelli A
PLoS One; 2016; 11(3):e0151156. PubMed ID: 27011009
[TBL] [Abstract][Full Text] [Related]
4. Detection and Assessment of α-Synuclein Oligomers in the Urine of Parkinson's Disease Patients.
Nam D; Lee JY; Lee M; Kim J; Seol W; Son I; Ho DH
J Parkinsons Dis; 2020; 10(3):981-991. PubMed ID: 32444560
[TBL] [Abstract][Full Text] [Related]
5. Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease.
Wang X; Yu S; Li F; Feng T
Neurosci Lett; 2015 Jul; 599():115-9. PubMed ID: 25998655
[TBL] [Abstract][Full Text] [Related]
6. Significant Changes in Plasma Alpha-Synuclein and Beta-Synuclein Levels in Male Children with Autism Spectrum Disorder.
Sriwimol W; Limprasert P
Biomed Res Int; 2018; 2018():4503871. PubMed ID: 29850516
[TBL] [Abstract][Full Text] [Related]
7. Prospect of Alpha-Synuclein (A-Syn) Isolation From Saliva as a Promising Diagnostic Biomarker Alternative in Parkinson's Disease (PD): A Systematic Review.
Muddaloor P; Farinango M; Ansary A; Dakka A; Nazir Z; Shamim H; Jean M; Umair M; Khan S
Cureus; 2022 Oct; 14(10):e29880. PubMed ID: 36348879
[TBL] [Abstract][Full Text] [Related]
8. Salivary alpha-synuclein in the diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
Vivacqua G; Suppa A; Mancinelli R; Belvisi D; Fabbrini A; Costanzo M; Formica A; Onori P; Fabbrini G; Berardelli A
Parkinsonism Relat Disord; 2019 Jun; 63():143-148. PubMed ID: 30796010
[TBL] [Abstract][Full Text] [Related]
9. Investigation of α-Synuclein Species in Plasma Exosomes and the Oligomeric and Phosphorylated α-Synuclein as Potential Peripheral Biomarker of Parkinson's Disease.
Zheng H; Xie Z; Zhang X; Mao J; Wang M; Wei S; Fu Y; Zheng H; He Y; Chen H; Xu Y
Neuroscience; 2021 Aug; 469():79-90. PubMed ID: 34186110
[TBL] [Abstract][Full Text] [Related]
10. Salivary alpha-synuclein as a biomarker for Parkinson's disease: a systematic review.
Bougea A; Koros C; Stefanis L
J Neural Transm (Vienna); 2019 Nov; 126(11):1373-1382. PubMed ID: 31401695
[TBL] [Abstract][Full Text] [Related]
11. Low Serum Level α-Synuclein and Tau Protein in Autism Spectrum Disorder Compared to Controls.
Kadak MT; Cetin I; Tarakçıoğlu MC; Özer ÖF; Kaçar S; Çimen B
Neuropediatrics; 2015 Dec; 46(6):410-5. PubMed ID: 26479762
[TBL] [Abstract][Full Text] [Related]
12. Plasma Levels of Alpha and Gamma Synucleins in Autism Spectrum Disorder: An Indicator of Severity.
Al-Mazidi S; Al-Ayadhi LY
Med Princ Pract; 2021; 30(2):160-167. PubMed ID: 33348337
[TBL] [Abstract][Full Text] [Related]
13. Total α-synuclein levels in human blood cells, CSF, and saliva determined by a lipid-ELISA.
Abd-Elhadi S; Basora M; Vilas D; Tolosa E; Sharon R
Anal Bioanal Chem; 2016 Nov; 408(27):7669-7677. PubMed ID: 27624766
[TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes.
Gustafsson G; Lindström V; Rostami J; Nordström E; Lannfelt L; Bergström J; Ingelsson M; Erlandsson A
J Neuroinflammation; 2017 Dec; 14(1):241. PubMed ID: 29228971
[TBL] [Abstract][Full Text] [Related]
15. Low serum Α-SYNUCLEIN and oligomer Α-SYNUCLEIN levels in multiple sclerosis patients.
Bilge N; Simsek F; Yevgi R; Ceylan M; Askın S
J Neuroimmunol; 2020 Nov; 350():577432. PubMed ID: 33220655
[TBL] [Abstract][Full Text] [Related]
16. Saliva α-Synuclein and A High Extinction Coefficient Protein: A Novel Approach in Assessment Biomarkers of Parkinson's Disease.
Al-Nimer MS; Mshatat SF; Abdulla HI
N Am J Med Sci; 2014 Dec; 6(12):633-7. PubMed ID: 25599051
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of α-synuclein oligomer in the cerebrospinal fluid of drug-naïve patients with Parkinson's disease.
Park MJ; Cheon SM; Bae HR; Kim SH; Kim JW
J Clin Neurol; 2011 Dec; 7(4):215-22. PubMed ID: 22259618
[TBL] [Abstract][Full Text] [Related]
18. Serum and salivary immunoglobulin G4 levels in children with autism spectrum disorder from south India: a case-control study.
Bhat SS; Kalal BS; Veena KM; Kakunje A; Sahana KSR; Rekha PD; Chandra J; Nasreen I
Am J Clin Exp Immunol; 2021; 10(4):103-111. PubMed ID: 35106187
[TBL] [Abstract][Full Text] [Related]
19. Salivary alpha-synuclein as a potential fluid biomarker in Parkinson's disease: A systematic review and meta-analysis.
Kharel S; Ojha R; Bist A; Joshi SP; Rauniyar R; Yadav JK
Aging Med (Milton); 2022 Mar; 5(1):53-62. PubMed ID: 35309157
[TBL] [Abstract][Full Text] [Related]
20. Baicalein inhibits α-synuclein oligomer formation and prevents progression of α-synuclein accumulation in a rotenone mouse model of Parkinson's disease.
Hu Q; Uversky VN; Huang M; Kang H; Xu F; Liu X; Lian L; Liang Q; Jiang H; Liu A; Zhang C; Pan-Montojo F; Zhu S
Biochim Biophys Acta; 2016 Oct; 1862(10):1883-90. PubMed ID: 27425033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
